247 related articles for article (PubMed ID: 30734484)
1. Alteration in gene expression profile of thymomas with or without myasthenia gravis linked with the nuclear factor-kappaB/autoimmune regulator pathway to myasthenia gravis pathogenesis.
Guo F; Wang CY; Wang S; Zhang J; Yan YJ; Guan ZY; Meng FJ
Thorac Cancer; 2019 Mar; 10(3):564-570. PubMed ID: 30734484
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of DNMT3a expression by RNAi and its effect on NF-κBs expression of thymic epithelial cells.
Meng FJ; Guo F; Sun ZN; Wang SJ; Yang CR; Wang CY; Zhang WC; Gao ZY; Ji LL; Feng FK; Guan ZY; Wang GS
Immunol Lett; 2021 Sep; 237():17-26. PubMed ID: 34192561
[TBL] [Abstract][Full Text] [Related]
3. Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes.
Yamada Y; Weis CA; Thelen J; Sticht C; Schalke B; Ströbel P; Marx A
Front Immunol; 2020; 11():664. PubMed ID: 32373124
[TBL] [Abstract][Full Text] [Related]
4. Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms.
Ströbel P; Chuang WY; Chuvpilo S; Zettl A; Katzenberger T; Kalbacher H; Rieckmann P; Nix W; Schalke B; Gold R; Müller-Hermelink HK; Peterson P; Marx A
Ann N Y Acad Sci; 2008; 1132():143-56. PubMed ID: 18567864
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune regulator expression in thymomas with or without autoimmune disease.
Liu Y; Zhang H; Zhang P; Meng F; Chen Y; Wang Y; Yao Y; Qi B
Immunol Lett; 2014 Sep; 161(1):50-6. PubMed ID: 24768600
[TBL] [Abstract][Full Text] [Related]
6. Familial autoimmune myasthenia gravis and thymoma: occurrence in two brothers.
Pascuzzi RM; Sermas A; Phillips LH; Johns TR
Neurology; 1986 Mar; 36(3):423-7. PubMed ID: 3951715
[TBL] [Abstract][Full Text] [Related]
7. Systems biology of myasthenia gravis, integration of aberrant lncRNA and mRNA expression changes.
Luo Z; Li Y; Liu X; Luo M; Xu L; Luo Y; Xiao B; Yang H
BMC Med Genomics; 2015 Mar; 8():13. PubMed ID: 25889429
[TBL] [Abstract][Full Text] [Related]
8. Genomic organization and lack of transcription of the nicotinic acetylcholine receptor subunit genes in myasthenia gravis-associated thymoma.
Geuder KI; Marx A; Witzemann V; Schalke B; Kirchner T; Müller-Hermelink HK
Lab Invest; 1992 Apr; 66(4):452-8. PubMed ID: 1583885
[TBL] [Abstract][Full Text] [Related]
9. Multiomics data reveals the influences of myasthenia gravis on thymoma and its precision treatment.
Ruan X; Lu X; Gao J; Jiang L; Zhu Y; Zhou Y; Meng J; Yan H; Yan F; Wang F
J Cell Physiol; 2021 Feb; 236(2):1214-1227. PubMed ID: 32700803
[TBL] [Abstract][Full Text] [Related]
10. Genetic characterization of thymoma.
Yu L; Ke J; Du X; Yu Z; Gao D
Sci Rep; 2019 Feb; 9(1):2369. PubMed ID: 30787364
[TBL] [Abstract][Full Text] [Related]
11. Cloning of a cDNA coding for the acetylcholine receptor alpha-subunit from a thymoma associated with myasthenia [correction of myastenia] gravis.
Gattenlöhner S; Brabletz T; Schultz A; Marx A; Müller-Hermelink HK; Kirchner T
Thymus; 1994; 23(2):103-13. PubMed ID: 7725386
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of miR-125a-5p in thymoma-associated myasthenia gravis and its down-regulation of foxp3 expression in Jurkat cells.
Li J; Qiu D; Chen Z; Du W; Liu J; Mo X
Immunol Lett; 2016 Apr; 172():47-55. PubMed ID: 26875774
[TBL] [Abstract][Full Text] [Related]
13. Alteration in gene expression profiles of thymoma: Genetic differences and potential novel targets.
Meng FJ; Wang S; Zhang J; Yan YJ; Wang CY; Yang CR; Guan ZY; Wang CL
Thorac Cancer; 2019 May; 10(5):1129-1135. PubMed ID: 30932350
[TBL] [Abstract][Full Text] [Related]
14. Aberrant decrease of microRNA19b regulates TSLP expression and contributes to Th17 cells development in myasthenia gravis related thymomas.
Wang Z; Chen Y; Xu S; Yang Y; Wei D; Wang W; Huang X
J Neuroimmunol; 2015 Nov; 288():34-9. PubMed ID: 26531692
[TBL] [Abstract][Full Text] [Related]
15. LncRNA and mRNA expression associated with myasthenia gravis in patients with thymoma.
Ke J; Du X; Cui J; Yu L; Li H
Thorac Cancer; 2022 Jan; 13(1):15-23. PubMed ID: 34773374
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling of thymoma with myasthenia gravis: Risk factors of developing myasthenia gravis in thymoma patients.
Lee MC; Hsiao TH; Chuang HN; Lee LW; Chi PL; Tsai HM; Mao CL; Hsu CP
Lung Cancer; 2020 Jan; 139():157-164. PubMed ID: 31809976
[TBL] [Abstract][Full Text] [Related]
17. Genetic association of Ctla-4 to myasthenia gravis with thymoma.
Huang D; Liu L; Norén K; Xia SQ; Trifunovic J; Pirskanen R; Lefvert AK
J Neuroimmunol; 1998 Aug; 88(1-2):192-8. PubMed ID: 9688341
[TBL] [Abstract][Full Text] [Related]
18. Type B thymomas in patients with myasthenia gravis display a distinctive pattern of αβ TCR and IL-7 receptor α expression on CD4
Wang T; Wang B; Fan X; Cai Y; Li L; Fu S
Autoimmunity; 2024 Apr; 57(1):2347379. PubMed ID: 38723105
[TBL] [Abstract][Full Text] [Related]
19. Association of acetylcholine receptor alpha-subunit gene expression in mixed thymoma with myasthenia gravis.
Wilisch A; Gutsche S; Hoffacker V; Schultz A; Tzartos S; Nix W; Schalke B; Schneider C; Müller-Hermelink HK; Marx A
Neurology; 1999 Apr; 52(7):1460-6. PubMed ID: 10227635
[TBL] [Abstract][Full Text] [Related]
20. Invasive medullary thymoma associated with Myasthenia gravis: an unusual case.
Reis Filho JS; Milanezi MF; Moreira CG; Werneck LC; Boscardin P; Ioshii SO; Schmitt FC
Arq Neuropsiquiatr; 2000 Dec; 58(4):1110-4. PubMed ID: 11105080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
